Bid guide
How to bid on BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
What BARDA is buying and why it matters
The Department of Health and Human Services, through BARDA, is looking for contractors to develop and produce medical countermeasures (MCMs) for pandemic influenza preparedness and response. This includes vaccines, antigens, and adjuvants.
Contractors will be responsible for manufacturing these items, supporting rapid regulatory decisions by submitting data to the FDA, and improving influenza vaccines. This work is crucial for public health emergencies and pandemic readiness.
Key dates and what happens at the deadline
This is a Request for Information (RFI) published on July 30, 2026. The deadline for responses is August 15, 2026, at 5:00 PM ET. At the deadline, BARDA will stop accepting submissions.
An RFI is used by an agency to gather information and assess market capabilities. It is not a solicitation for offers, and the government is not obligated to award a contract based on responses to this RFI.
Who this opportunity suits
This opportunity is for companies that produce vaccines against influenza and influenza strains with pandemic potential. You must demonstrate successful experience in manufacturing influenza vaccines.
To be eligible, your firm must either hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by the submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine. This falls under the professional services category.
How to respond
To access the full details of this opportunity, you will need to view the original source on the portal. Click the “View original source” link. If the first click takes you to the portal’s homepage, click it again to go directly to the bid.
You may need to create a free account on the portal to view all documents, though for some bids, an account is not required.
Tips for preparing a competitive response
Even though this is an RFI, provide clear and concise information about your firm's capabilities and experience. Highlight your specific expertise in influenza vaccine manufacturing and your regulatory track record with the FDA.
Ensure your response directly addresses all mandatory qualification requirements. Clearly state whether you hold a U.S. influenza vaccine license or have submitted a BLA, providing relevant details. Focus on demonstrating your capacity to meet the program's objectives for pandemic preparedness and response.
See the live bid — deadline, agency details, and how to respond
Dates and requirements can change via addenda; always verify on the bid page and at the original source before responding.
View this bid on BiddingSimpleThis guide was prepared by BiddingSimple from the solicitation’s public posting. It is not official guidance from Health and Human Services, Department of; the original posting controls.